RPS6KB1 and plasma cell myeloma: Shi et al [11, 12] demonstrated that IL-6 or IGF-1 exposure up-regulated phosphorylation of p70S6K and 4EBP-1 and that the mTOR inhibitors may prevent activation of the mTOR pathway by inhibiting cytokine-dependent myeloma cell growth.